Harnessing our research to offer innovative diagnostic testing

Our story

SDxLabs is a CLIA Certified high complexity molecular diagnostic laboratory that is operated by SignatureDx. Signature is a local research company focused on the development of early-stage diagnostic and phenotyping tools for complex disease in collaboration with the University of Pittsburgh and Magee-Womens Research Institute and Foundation.

Our diagnostic laboratory, SDxLabs was created to deliver our own tests, as well as other established ones like COVID-19 infection testing, to local communities in the Pittsburgh region.

Based on intellectual property jointly developed by the University of Pittsburgh and Magee Women’s research Institute, the work to discover these diagnostic tools utilizes cell-free DNA and other biomarkers that are obtained using non-invasive sample techniques. Current projects are focused on women’s reproductive health and organs.

Our mission

is to equip the communities we serve with innovative diagnostic procedures to take a proactive approach to health care.

Our vision

is to expand access to cutting edge diagnostics, enabling early disease detection to elevate the standard of care.

This is an exciting opportunity to translate our research efforts into commercial products that will improve patient health outcomes. We want to make our novel solutions available to as many people as possible so that we may help them make proactive healthcare decisions that will have a positive impact on their health.”

David G. Peters, PhD
Co-founder and Chief Science Officer

David-Peters

The framework on which we work is our core values

  • Integrity and Quality

    We uphold the integrity and quality of our research and data so those we serve can put their trust in us to deliver cutting-edge diagnostic tests with results that are accurate and reliable.

  • Committed

    We are committed to increasing access to diagnostic testing to help detect disease early giving patients the best chance at successful treatment.

  • Dedication and Impact

    We are dedicated to our research to deliver impactful solutions using technology to improve and reshape the healthcare sector.

  • Passion

    Our passion for proactive medicine and early intervention drives us to create new, noninvasive diagnostic tests that elevate patient comfort and lower the risk of complications.

  • Collaboration

    Our multi-disciplined team collaborates to provide a holistic, unique approach to developing solutions that will improve health outcomes for patients and enhanced satisfaction of clients.

Discover our research focused on the development of early-stage diagnostic and phenotyping tools for complex disease